Pinnacle Biologics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $45M

Pinnacle Biologics General Information

Description

Developer of bio-pharmaceutical drugs. The company develops therapies for oncology and other diseases.

Contact Information

Website
www.pinnaclebiologics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2801 Lakeside Drive
  • Suite 209
  • Deerfield, IL 60015
  • United States
+1 (847)
Primary Industry
Pharmaceuticals
Acquirer
Advanz Pharma
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2801 Lakeside Drive
  • Suite 209
  • Deerfield, IL 60015
  • United States
+1 (847)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pinnacle Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Dec-2013 $45M Completed Profitable
3. Later Stage VC 20-Dec-2012 Completed Profitable
2. Early Stage VC (Series A) 29-Dec-2011 $1.5M $1.63M Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 10-Jun-2008 $132K $132K Completed Product Development
To view Pinnacle Biologics’s complete valuation and funding history, request access »

Pinnacle Biologics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Pinnacle Biologics’s complete cap table history, request access »

Pinnacle Biologics Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Pinnacle Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220354953-A1 Photodynamic therapy compositions and methods of treatment therein Pending 20-Jul-2021
AU-2022316132-A1 Photodynamic therapy compositions and methods of treatment therein Pending 20-Jul-2021
CA-3226378-A1 Photodynamic therapy compositions and methods of treatment therein Pending 20-Jul-2021
EP-4373524-A1 Photodynamic therapy compositions and methods of treatment therein Pending 20-Jul-2021
AU-2021339814-A1 Photodynamic therapy compositions and methods of use thereof Pending 11-Sep-2020 A61K41/0057
To view Pinnacle Biologics’s complete patent history, request access »

Pinnacle Biologics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Esperante Ventures Corporate Venture Capital Minority
Numoda Capital Innovations Venture Capital Minority
To view Pinnacle Biologics’s complete investors history, request access »

Pinnacle Biologics Investments (1)

Pinnacle Biologics’s most recent deal was a Corporate Asset Purchase with Axcan (Photofrin and Photobarr). The deal was made on 29-Mar-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Axcan (Photofrin and Photobarr) 29-Mar-2011 Corporate Asset Purchase Buildings and Property
To view Pinnacle Biologics’s complete investments history, request access »

Ready to get started?

Request a free trial

Pinnacle Biologics FAQs

  • When was Pinnacle Biologics founded?

    Pinnacle Biologics was founded in 2007.

  • Where is Pinnacle Biologics headquartered?

    Pinnacle Biologics is headquartered in Deerfield, IL.

  • What industry is Pinnacle Biologics in?

    Pinnacle Biologics’s primary industry is Pharmaceuticals.

  • Is Pinnacle Biologics a private or public company?

    Pinnacle Biologics is a Private company.

  • What is the current valuation of Pinnacle Biologics?

    The current valuation of Pinnacle Biologics is .

  • What is Pinnacle Biologics’s current revenue?

    The current revenue for Pinnacle Biologics is .

  • How much funding has Pinnacle Biologics raised over time?

    Pinnacle Biologics has raised $1.63M.

  • Who are Pinnacle Biologics’s investors?

    Esperante Ventures and Numoda Capital Innovations have invested in Pinnacle Biologics.

  • When was Pinnacle Biologics acquired?

    Pinnacle Biologics was acquired on 24-Dec-2013.

  • Who acquired Pinnacle Biologics?

    Pinnacle Biologics was acquired by Advanz Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »